TIAA CREF Investment Management’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$3.57M Buy
3,591
+365
+11% +$339K ﹤0.01% 1655
2018
Q4
$2.8M Sell
3,226
-65
-2% -$60.4K ﹤0.01% 1750
2018
Q3
$3.4M Sell
3,291
-284
-8% -$278K ﹤0.01% 1838
2018
Q2
$3.29M Buy
3,575
+622
+21% +$668K ﹤0.01% 1895
2018
Q1
$2.88M Buy
2,953
+474
+19% +$432K ﹤0.01% 1901
2017
Q4
$1.12M Sell
2,479
-73
-3% -$27K ﹤0.01% 2411
2017
Q3
$1.06M Sell
2,552
-164
-6% -$61.8K ﹤0.01% 2488
2017
Q2
$950K Buy
2,716
+187
+7% +$72K ﹤0.01% 2573
2017
Q1
$1.3M Sell
2,529
-198
-7% -$82K ﹤0.01% 2388
2016
Q4
$968K Sell
2,727
-48
-2% -$20.3K ﹤0.01% 2558
2016
Q3
$1.48K Sell
2,775
-90
-3% -$48.9K ﹤0.01% 2339
2016
Q2
$1.61M Buy
2,865
+787
+38% +$378K ﹤0.01% 2255
2016
Q1
$989K Sell
2,078
-873
-30% -$393K ﹤0.01% 2478
2015
Q4
$1.95M Sell
2,951
-59
-2% -$44.6K ﹤0.01% 2173
2015
Q3
$2.37M Buy
3,010
+400
+15% +$488K ﹤0.01% 2042
2015
Q2
$3.44M Buy
2,610
+1,845
+241% +$2.12M ﹤0.01% 1946
2015
Q1
$795K Buy
765
+650
+565% +$430K ﹤0.01% 2741
2014
Q4
$77K Buy
+115
New +$70.2K ﹤0.01% 3125

Other funds holding ATRA